ArticlePloS one2025
Mapping Important Shark and Ray Areas (ISRAs) in the Central and South American Pacific: Existing knowledge and data needs.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Prioritizing Shark, Ray, and Chimaera Conservation in Rapidly Changing Polar Waters.Global change biology · 2026Article
- One Assay to Rule Them All: Development of a Global Environmental DNA Tool to Support Range-Wide Surveys of an Imperiled Sawfish and Its Application in the Eastern Tropical Pacific.Ecology and evolution · 2026Article
- Only One Percent of Important Shark and Ray Areas in the Western Indian Ocean Are Fully Protected From Fishing Pressure.Ecology and evolution · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
25 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Identifying critical habitats is key to the conservation and recovery of threatened species. A third of chondrichthyans (sharks, rays, and chimaeras) are threatened with extinction but robust biological and ecological information to delineate critical habitats for many species remains limited. Here, we investigated (1) research outputs and trends across the Central and South American Pacific region to determine whether sufficient information was available to identify critical habitats; (2) whether regional Important Shark and Ray Areas (ISRAs) were spatially representative; (3) what species and which ecological traits were most commonly used in the delineation of critical habitats; and (4) discuss how ISRAs can inform research priorities and area-based management in support of chondrichthyan conservation. Sixty-five ISRAs were identified for 97 of 190 chondrichthyan species occurring in the region (51%). Across key life-history processes, reproductive areas were most identified (n = 50). Of 821 published studies (2,160 entries), 31.48% (28% entries) primarily focused on fisheries and 48.51% included enough information to inform the ISRA process. Most (58.98%) of these studies originated from Mexico (n = 342, 744 entries) and Ecuador (n = 147, 276 entries). France and Honduras had the least regional research outputs relevant to apply the ISRA Criteria. Significant ecological data gaps were identified in oceanic (including areas beyond national jurisdiction), deepwater (>200 m), and along the southern part of the region (i.e., southern Chile). Deepwater species, chimaeras, and 21% of threatened species had knowledge gaps that did not allow the identification of ISRAs. If area-based management decisions in this region were based on ISRAs, and effectively implemented and enforced, diversity hotspots and at least 97 species could receive protection, including 79% of threatened species and 54% of those considered range-restricted. Increased monitoring and research efforts, with a corresponding increase in funding to fill existing gaps is key to support the identification of important habitats across this region.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.